Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides:: a comparative study

被引:196
作者
El-Andaloussi, Samir
Jarver, Peter [1 ]
Johansson, Henrik J.
Langel, Ulo
机构
[1] Stockholm Univ, Dept Neurochem, S-16091 Stockholm, Sweden
[2] Univ Tartu, Inst Technol, Lab Mol Biotechnol, EE-50090 Tartu, Estonia
关键词
cell-penetrating peptide; cytotoxicity; delivery vector; penetratin; transactivator of transcription (Tat); transport;
D O I
10.1042/BJ20070507
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The use of CPPs (cell-penetrating peptides) as delivery vectors for bioactive molecules has been an emerging field since 1994 when the first CPP, penetratin, was discovered. Since then, several CPPs, including the widely used Tat (transactivator of transcription) peptide, have been developed and utilized to translocate a wide range of compounds across the plasma membrane of cells both in vivo and in vitro. Although the field has emerged as a possible future candidate for drug delivery, little attention has been given to the potential toxic side effects that these peptides might exhibit in cargo delivery. Also, no comprehensive study has been performed to evaluate the relative efficacy of single CPPs to convey different cargos. Therefore we selected three of the major CPPs, penetratin, Tat and transportan 10, and evaluated their ability to deliver commonly used cargos, including fluoresceinyl moiety, double-stranded DNA and proteins (i.e. avidin and streptavidin), and studied their effect on membrane integrity and cell viability. Our results demonstrate the unfeasibility to use the translocation efficacy of fluorescein moiety as a gauge for CPP efficiency, since the delivery properties are dependent on the cargo used. Furthermore, and no less importantly, the toxicity of CPPs depends heavily on peptide concentration, cargo molecule and coupling strategy.
引用
收藏
页码:285 / 292
页数:8
相关论文
共 29 条
[1]   Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound [J].
Bykov, VJN ;
Issaeva, N ;
Shilov, A ;
Hultcrantz, M ;
Pugacheva, E ;
Chumakov, P ;
Bergman, J ;
Wiman, KG ;
Selivanova, G .
NATURE MEDICINE, 2002, 8 (03) :282-288
[2]  
DEROSSI D, 1994, J BIOL CHEM, V269, P10444
[3]   On the mechanism of non-endosomial peptide-mediated cellular delivery of nucleic acids [J].
Deshayes, S ;
Gerbal-Chaloin, S ;
Morris, MC ;
Aldrian-Herrada, G ;
Charnet, P ;
Divita, G ;
Heitz, F .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2004, 1667 (02) :141-147
[4]   TP10, a delivery vector for decoy oligonucleotides targeting the Myc protein [J].
El-Andaloussi, S ;
Johansson, H ;
Magnusdottir, A ;
Järver, P ;
Lundberg, P ;
Langel, Ü .
JOURNAL OF CONTROLLED RELEASE, 2005, 110 (01) :189-201
[5]   Cell-penetrating peptides:: Mechanisms and applications [J].
El-Andaloussi, S ;
Holm, T ;
Langel, Ü .
CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (28) :3597-3611
[6]   Induction of splice correction by cell-penetrating peptide nucleic acids [J].
El-Andaloussi, Samir ;
Johansson, Henrik J. ;
Lundberg, Pontus ;
Langel, Ulo .
JOURNAL OF GENE MEDICINE, 2006, 8 (10) :1262-1273
[7]   Extending the applicability of carboxyfluorescein in solid-phase synthesis [J].
Fischer, R ;
Mader, O ;
Jung, G ;
Brock, R .
BIOCONJUGATE CHEMISTRY, 2003, 14 (03) :653-660
[8]   Studying the uptake of cell-penetrating peptides [J].
Holm, Tina ;
Johansson, Henrik ;
Lundberg, Pontus ;
Pooga, Margus ;
Lindgren, Maria ;
Langel, Ulo .
NATURE PROTOCOLS, 2006, 1 (02) :1001-1005
[9]   Penetratin improves tumor retention of single-chain antibodies: A novel step toward optimization of radioimmunotherapy of solid tumors [J].
Jain, M ;
Chauhan, SC ;
Singh, AP ;
Venkatraman, G ;
Colcher, D ;
Batra, SK .
CANCER RESEARCH, 2005, 65 (17) :7840-7846
[10]   The use of cell-penetrating peptides as a tool for gene regulation [J].
Järver, P ;
Langel, Ü .
DRUG DISCOVERY TODAY, 2004, 9 (09) :395-402